MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

by Horiuchi, Dai, Kusdra, Leonard, Huskey, Noelle E., Chandriani, Sanjay, Lenburg, Marc E., Gonzalez-Angulo, Ana Maria, Creasman, Katelyn J., Bazarov, Alexey V., Smyth, James W., Davis, Sarah E., Yaswen, Paul, Mills, Gordon B., Esserman, Laura J., Goga, Andrei
Published 2012